If you’re considering Wegovy for weight management, you’ve probably come across concerns about potential side effects. One question that often comes up is: Does Wegovy cause blood clots? This is an important concern, especially if you have a history of clotting issues or other risk factors.
Wegovy (semaglutide) is a GLP-1 receptor agonist approved by the FDA for chronic weight management. It works by mimicking a natural hormone that helps regulate appetite and blood sugar. Many people use it successfully to support weight loss and improve their overall health.
Understanding the relationship between Wegovy and blood clots requires looking at what we know about the medication, how it works in your body, and what factors might influence your personal risk. This guide breaks down the facts in plain language so you can make informed decisions with your healthcare provider.
Understanding Wegovy And Blood Clot Concerns
Wegovy is the brand name for semaglutide when it’s prescribed specifically for weight management. It belongs to a class of medications called GLP-1 receptor agonists. These medications work by mimicking a hormone your body naturally produces to help control appetite and blood sugar levels.
The concern about blood clots often arises because obesity itself can increase the risk of developing clots. When you carry excess weight, your blood may be more likely to clot. Circulation can be affected as well. This means people who are candidates for Wegovy may already have some baseline risk.
It’s important to understand that having a higher risk due to obesity is different from a medication directly causing blood clots. Wegovy is designed to help reduce weight. This may actually lower some cardiovascular risks over time. Your doctor can help you understand your personal risk profile.
Some patients also worry because they’ve heard about blood clot concerns with other medications or medical conditions. While it’s smart to stay informed, it’s also helpful to separate general health risks from medication-specific side effects. The FDA label for Wegovy does not list blood clots as a known side effect.
Blood clots can form in veins or arteries. Deep vein thrombosis (DVT) and pulmonary embolism (PE) are two types of venous clots that people often ask about. These conditions can happen for many reasons:
-
- Prolonged sitting or limited movement
- Recent surgery or injury
- Certain medical conditions
- Genetic factors
If you have a history of blood clots, your doctor will likely discuss this with you before prescribing Wegovy. They may recommend monitoring or additional precautions based on your individual health history. Open communication with your healthcare provider is key to managing any potential risks safely.
Current Research On Wegovy And Blood Clots
In a 2025 systematic review and meta-analysis, researchers found no statistically significant difference in overall venous thromboembolism (VTE) risk between GLP-1 receptor agonists and placebo. FDA findings also did not identify venous thromboembolism (VTE) as an adverse event.
It’s important to remember that all medications are monitored over time for rare or unexpected side effects. Healthcare providers and regulatory agencies continue to track safety data as more people use Wegovy. Staying informed and maintaining regular check-ins with your doctor can help you manage any potential risks.
What Clinical Studies Show
Large clinical trials provide the most reliable information about medication safety. Two major trial programs have examined blood clot rates in people taking Wegovy compared to those taking placebo. These trials included thousands of participants and tracked their health outcomes over time.
The STEP trials enrolled around 4,500 participants. Blood clot rates were similar between the Wegovy and placebo groups. The SELECT trial included over 17,000 participants. It also showed comparable rates of blood clots in both groups. These findings suggest that semaglutide does not increase the risk of clotting events.
Here’s a summary of what these trials found:
| Study | Participants | Blood Clot Rate (Wegovy) | Blood Clot Rate (Placebo) |
| STEP Trials | 4,500 | Similar to placebo | Similar to Wegovy |
| SELECT Trial | 17,604 | Similar to placebo | Similar to Wegovy |
These numbers show that the risk of blood clots, including deep vein thrombosis (DVT), was not higher in people taking Wegovy. This can help ease concerns about semaglutide and blood clots for many patients.
Understanding VTE Risk
Venous thromboembolism (VTE) is a medical term that covers blood clots forming in the veins. This includes two main types: deep vein thrombosis (DVT) and pulmonary embolism (PE). DVT occurs when a clot forms in the deep veins of the legs. PE happens when a clot travels to the lungs.
People often ask whether semaglutide increases the risk of these specific types of clots. Based on available information, rates of VTE events in clinical trials were similar between people taking semaglutide and those taking placebo. This suggests that Wegovy does not significantly raise the risk of DVT or PE.
Medical professionals continue to monitor for rare events as more people use GLP-1 medications. If you have a personal or family history of blood clots, it’s important to discuss this with your doctor before starting Wegovy. They can help you understand your individual risk and decide on the best approach for your health.
Potential Heart Health Benefits
While concerns about blood clots are understandable, it’s also worth noting that GLP-1 receptor agonists like Wegovy may offer cardiovascular benefits. Losing weight can improve heart health, which reduces some risk factors associated with clotting. Losing excess pounds often leads to better circulation and lower inflammation.
The relationship between GLP-1 medications and cardiovascular health is complex. Rather than increasing clot risk, these medications may actually support heart and blood vessel health through weight reduction and metabolic improvements, with studies showing 13% reduction in cardiovascular events in patients with type 2 diabetes. Your healthcare provider can help you weigh the potential benefits against any personal risk factors you may have.
Factors That May Influence Clot Risk
Your personal health profile often matters more than the medication itself when it comes to blood clot risk. Understanding your individual risk factors can help you and your doctor make the safest decisions about using Wegovy.
Personal Health Conditions
Certain health conditions can raise your risk of developing blood clots, regardless of whether you take Wegovy. Higher body weight is one of the most significant factors. When you carry excess weight, your blood may be more likely to clot. Circulation can slow down as well.
Limited mobility can also increase clot risk. If you sit for long periods or have difficulty moving around, blood flow in your legs may slow. This can lead to clot formation. This is why doctors often recommend staying active and moving regularly, even if it’s just short walks throughout the day.
Other health conditions can contribute to clotting risk:
-
- Diabetes: Can affect blood vessel health and circulation.
- Heart disease: May increase overall cardiovascular risk.
- Previous blood clots: Having one clot raises the risk of developing another.
When patients ask, “Can Wegovy cause blood clots?” the answer often depends more on these individual risk factors than on the medication itself. Your baseline health status, activity level, and medical history all influence your overall risk. This is why personalized medical care is so important.
Medication Interactions
Some medications you’re already taking can affect your blood clot risk. It’s important to discuss these with your healthcare provider before starting Wegovy. Certain drug combinations require careful monitoring to ensure your safety.
Blood thinners such as warfarin (anticoagulants) are often prescribed to people who have a higher risk of clots. These medications can usually be safely combined with Wegovy under medical supervision. Your doctor may want to monitor you more closely if you’re taking both. Many patients use them together without problems.
Hormonal medications like birth control pills and hormone replacement therapy can increase clot risk on their own. If you’re taking these medications, it’s especially important to discuss your overall risk profile with your provider. They may recommend additional monitoring or suggest alternative options if needed.
Always tell your doctor about every medication you take, including over-the-counter drugs and supplements. This complete picture helps them assess your risk and make the best recommendations for your health.
Recognizing Warning Signs
Staying aware of potential side effects and knowing when to seek help can make your experience with Wegovy safer and more comfortable. While blood clots are not a common side effect, understanding the warning signs can help you act quickly if something doesn’t feel right.
Knowing what to watch for can help you catch potential problems early. Blood clots can cause specific symptoms that shouldn’t be ignored. If you notice any of these signs while taking Wegovy, it’s important to take them seriously and contact your doctor right away.
Leg symptoms are often the first sign of a deep vein thrombosis (DVT):
-
- Swelling in one leg, especially the calf
- Pain or tenderness in the leg
- Redness or warmth in the affected area
- Symptoms typically affect only one leg at a time
Chest symptoms can indicate a more serious problem, such as a pulmonary embolism (PE):
-
- Shortness of breath that comes on suddenly
- Chest pain that worsens with deep breathing
- Rapid heartbeat or irregular pulse
- Coughing, sometimes with blood
Emergency signs require immediate action. If you experience sudden severe symptoms like difficulty breathing, fainting, or severe chest pain, call 911 or go to the nearest emergency room. Don’t wait to see if symptoms improve on their own.
When To Contact Your Doctor
Regular communication with your healthcare provider is one of the most important steps you can take while using Wegovy. Your doctor can help you understand your personal risk factors and monitor your health throughout treatment.
Before starting Wegovy, schedule a thorough discussion with your healthcare provider about your medical history. Talk about any personal or family history of blood clots. Discuss other risk factors like limited mobility, recent surgery, or hormonal medications. This conversation helps your doctor determine if Wegovy is right for you and what precautions might be needed.
During treatment, maintain regular check-ins with your provider as recommended. These appointments allow your doctor to monitor your progress. They can adjust your dosage if needed. They can address any new symptoms or concerns. Don’t hesitate to report changes in how you feel, even if they seem minor.
If symptoms develop, seek medical advice immediately. Any warning signs of blood clots should be evaluated promptly, even if you’re not sure they’re related to Wegovy. Your provider can help determine the safest course of action based on your individual health profile and symptoms.
Comparing GLP-1 Medications
GLP-1 medications are not all the same, and information about blood clot risk can vary between them. If you’re exploring different options for Wegovy, it’s helpful to understand how these medications compare.
Three GLP-1 medications are commonly prescribed: Wegovy, Ozempic, and Zepbound. While they work in nearly similar ways, they have different active ingredients and approved uses. Understanding these differences can help you have more informed conversations with your healthcare provider.
Wegovy and Ozempic both contain semaglutide as their active ingredient. Wegovy is specifically approved for chronic weight management. Ozempic is approved for type 2 diabetes management. Because they share the same active ingredient, their safety profiles are similar.
Zepbound contains tirzepatide, a different active ingredient. It works on both GLP-1 and GIP receptors. It’s approved for weight management. Because tirzepatide is newer, long-term safety data is still being collected.
Here’s a quick comparison:
| Medication | Active Ingredient | Primary Use | Blood Clot Research |
|---|---|---|---|
| Wegovy | Semaglutide | Weight management | No increased risk found |
| Ozempic | Semaglutide | Diabetes management | Similar safety profile |
| Zepbound | Tirzepatide | Weight loss | Limited long-term data |
Current information does not show an increased risk of blood clots with Ozempic or Zepbound. Because Ozempic contains the same active ingredient as Wegovy, concerns about “Ozempic and blood clots” are addressed by the same clinical trial data. For Zepbound, ongoing monitoring continues as more patients use the medication over time.
If you’re considering switching between these medications or starting a new one, talk to your healthcare provider about your specific health needs. They can help you choose the option that best fits your medical history and treatment goals.
Lifestyle Steps That May Help
While medication plays an important role in weight management and diabetes control, certain lifestyle habits may help reduce your overall blood clot risk. These simple practices can support your health whether you’re taking Wegovy or another GLP-1 medication.
These steps may help support your health and reduce risk factors that contribute to blood clots. They work alongside your medication to promote better overall wellness. Remember that every person’s health situation is different, so always discuss lifestyle changes with your healthcare provider before making major adjustments.
Managing Long-Term Treatment With Affordable Access
The cost of Wegovy can be a serious expense when you’re budgeting for your health. Many patients find that prescription prices in the United States are significantly higher than in other countries. This can make long-term treatment feel overwhelming. If you’re looking for more affordable options, ordering from a licensed online pharmacy can help reduce costs while maintaining safety and quality.
Only order medications with a valid prescription from your healthcare provider. Legitimate pharmacies will always require a prescription for medications like Wegovy. They will verify it with a licensed pharmacist before dispensing. If a website offers to sell you prescription medication without requiring a prescription, avoid it.
Buy Canadian Insulin partners with licensed Canadian pharmacies to provide Americans with affordable access to medications like Wegovy. Every prescription is verified by a US doctor and a Canadian pharmacist, ensuring safety and compliance. Medications are shipped express in insulated packaging to maintain proper storage conditions throughout delivery.
You can order Wegovy online at discounted prices from Buy Canadian Insulin. Customer support is available seven days a week to answer questions and help you navigate the ordering process. Contact us and learn how you can save on the medications you need.
Articles you may also be interested in
